ReadYourDNA

rs174577 (FADS2)

What you carry at this position in your DNA and what research says about it.

Omega-3 Synthesis: 8/10 evidence, 15 publications.

You're viewing every possible genotype for this variant.

None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.

Sample genotype (not yours): C/C

Efficient Omega-3 Synthesis

Efficient conversion of plant-based fats into active omega-3 fatty acids characterizes this metabolic profile.

What this genotype means: Highly efficient synthesis of DHA and EPA; Lower circulating triglyceride levels; Slightly higher LDL and total cholesterol.

Sample genotype (not yours): A/A

Reduced Omega-3 Synthesis

Less efficient conversion of plant-based fats into active omega-3s makes dietary sources of DHA more important.

What this genotype means: Inefficient synthesis of DHA and EPA; Higher circulating triglyceride levels; Slightly lower LDL and total cholesterol.

Sample genotype (not yours): C/A

Typical Omega-3 Synthesis

A balanced, intermediate rate of fatty acid conversion helps maintain typical lipid levels.

What this genotype means: Moderate synthesis of DHA and EPA; Typical triglyceride and cholesterol levels; Balanced overall lipid profile.

About FADS2

Gene function and biological role

Gene Function: The FADS2 gene encodes delta-6 desaturase, a rate-limiting enzyme crucial for lipid homeostasis [1]. This enzyme catalyzes the first step in converting plant-derived short-chain fatty acids into active long-chain polyunsaturated fatty acids [1]. These end products include docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which are vital for brain function and cardiovascular health [1]. FADS2 works in tandem with FADS1 within a highly regulated gene cluster on chromosome 11 [2]. Variations in this gene directly alter how efficiently the body synthesizes these essential fats from dietary sources [2].

Variant Impact: The rs174577 variant is an intronic change in the FADS2 gene that acts as a strong modifier of gene expression [3]. This genetic change alters DNA methylation patterns in the FADS cluster, directly impacting desaturase enzyme levels [3]. The C allele is associated with highly efficient conversion of dietary fats into long-chain omega-3 and omega-6 fatty acids [4]. Conversely, the A allele reduces this enzymatic conversion, leading to lower circulating levels of active polyunsaturated fatty acids [4]. This single change thus shifts the entire systemic balance of blood lipids and metabolic markers [3].

Key Insight: Your body's ability to create brain-essential DHA from plant oils like flaxseed depends heavily on this genetic variant.

Location: FADS2. Chromosome 11 · 11q12.2 · 61.8 Mb

Genotype Frequencies

Estimated prevalence by population

Global 39.4%; European 43.0%; African 39.9%; East Asian 19.9%; South Asian 66.9%; Americas 22.0%; Ashkenazi 48.6%; Finnish 33.4%; Middle Eastern 35.5%; Amish 54.9%.

Estimated CC genotype frequency.

Global 45.8%; European 45.2%; African 46.5%; East Asian 49.4%; South Asian 29.8%; Americas 49.8%; Ashkenazi 42.3%; Finnish 48.8%; Middle Eastern 48.2%; Amish 38.4%.

Estimated CA genotype frequency.

Global 14.7%; European 11.9%; African 13.6%; East Asian 30.6%; South Asian 3.3%; Americas 28.2%; Ashkenazi 9.2%; Finnish 17.8%; Middle Eastern 16.3%; Amish 6.7%.

Estimated AA genotype frequency.

Associated Traits

Showing effects for C/C genotype

Nutrition & Metabolism

Macronutrient Metabolism

Omega-3 Fatty Acids. Evidence: 8/10. Source: PMID 41044249. Higher Levels.

Cardiovascular & Metabolic

Lipids & Cholesterol

Triglycerides. Evidence: 8/10. Source: PMID 29507422. Lower Levels.

Cholesterol Levels. Evidence: 8/10. Source: PMID 29507422. Higher LDL.

Diabetes & Glycemic Traits

Blood Sugar Control. Evidence: 8/10. Source: PMID 28898252. Higher HbA1c.

Showing effects for A/A genotype

Omega-3 Fatty Acids. Evidence: 8/10. Source: PMID 41044249. Lower Levels.

Triglycerides. Evidence: 8/10. Source: PMID 29507422. Higher Levels.

Cholesterol Levels. Evidence: 8/10. Source: PMID 29507422. Lower LDL.

Blood Sugar Control. Evidence: 8/10. Source: PMID 28898252. Lower HbA1c.

Showing effects for C/A genotype

Omega-3 Fatty Acids. Evidence: 8/10. Source: PMID 41044249. Typical Levels.

Triglycerides. Evidence: 8/10. Source: PMID 29507422. Typical Levels.

Cholesterol Levels. Evidence: 8/10. Source: PMID 29507422. Typical LDL.

Blood Sugar Control. Evidence: 8/10. Source: PMID 28898252. Typical HbA1c.

What CC Genotype Means

What this genotype means for the people who carry it

Sample genotype: CC (Homozygous)

Possessing two copies of the C allele leads to highly active delta-6 desaturase enzymes [1]. This allows for the efficient conversion of short-chain plant fats into critical long-chain polyunsaturated fatty acids like DHA and EPA [1]. Studies show these individuals maintain higher circulating levels of omega-3 and omega-6 fatty acids [1]. They also tend to have lower fasting triglyceride levels [2]. However, this highly active metabolic state is a double-edged sword, as it is also associated with slightly higher total cholesterol, LDL cholesterol, and fasting blood glucose levels [2]. Ensuring a balanced diet rich in natural antioxidants can help optimize this metabolic profile.

Highly efficient synthesis of DHA and EPA; Lower circulating triglyceride levels; Slightly higher LDL and total cholesterol.

What AA Genotype Means

Sample genotype: AA (Homozygous)

Two copies of the A allele significantly reduce the activity of the delta-6 desaturase enzyme [1]. As a result, the body struggles to convert plant-derived short-chain fatty acids into active, long-chain polyunsaturated fatty acids like DHA [1]. This inefficient conversion often leads to lower circulating levels of essential omega-3 fatty acids [1]. Additionally, this genotype is linked to higher fasting triglyceride levels [2]. On the positive side, these individuals often benefit from lower total cholesterol, lower LDL cholesterol, and better blood sugar control [2]. To compensate for the reduced synthesis, focusing on direct dietary sources of preformed DHA and EPA is highly recommended.

Inefficient synthesis of DHA and EPA; Higher circulating triglyceride levels; Slightly lower LDL and total cholesterol.

What CA Genotype Means

Sample genotype: CA (Heterozygous)

A single copy of each allele provides a balanced metabolic middle ground [1]. The body converts plant-based alpha-linolenic acid into active DHA and EPA at a typical, moderate rate [1]. Circulating levels of omega-3 fatty acids and triglycerides generally fall within the average range for the population [2]. This intermediate desaturase activity also means that cholesterol and blood sugar levels are typically balanced, avoiding the higher extremes seen in other genotypes [2]. While there is no urgent need for high-dose supplementation, maintaining a diet with consistent sources of preformed omega-3s remains beneficial.

Moderate synthesis of DHA and EPA; Typical triglyceride and cholesterol levels; Balanced overall lipid profile.

Related Variants

Variants with shared genetic architecture

rs174570 · FADS2 Gene · Chr 11 · Fatty Acid Metabolism

rs174574 · FADS2 Gene · Chr 11 · Fatty Acid Metabolism

rs99780 · FADS2 Gene · Chr 11 · Omega-3 Metabolism

Sources

Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease.

Genome-Wide Association Study for Serum Omega-3 and Omega-6 Polyunsaturated Fatty Acids: Exploratory Analysis of the Sex-Specific Effects and Dietary Modulation in Mediterranean Subjects with Metabolic Syndrome.

Rare and common genetic determinants of metabolic individuality and their effects on human health.

A genetic map of human metabolism across the allele frequency spectrum.

A large electronic-health-record-based genome-wide study of serum lipids.

Back to Variant Explorer

Content updated August 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com